Haemonetics Corporation Acquires OpSens Inc.

onsemi to Acquire Synaptics

June 25, 2026

Manufacturing

onsemi agreed to acquire Synaptics in a deal first announced as an all-stock transaction valued at approximately $7 billion; the companies amended the agreement on October 1, 2026, to an all-cash offer of $123 per share, valued at approximately $5.7 billion. The acquisition is intended to expand onsemi’s edge AI, connected compute, human-machine interface, sensing, and wireless connectivity capabilities, with closing expected by mid-2027 subject to shareholder and regulatory approvals.

Danaher Completes Acquisition of Masimo Corporation

February 17, 2026

Healthcare Services

Danaher has completed its acquisition of Masimo Corporation, a specialty diagnostics provider focused on pulse oximetry and patient monitoring solutions primarily used in acute care settings. Masimo will become a wholly-owned subsidiary of Danaher and continue operating under the Masimo brand as a stand-alone operating company within Danaher’s Diagnostics segment.

Haemonetics Acquires Vivasure Medical

January 11, 2026

Medical Devices

Haemonetics Corporation has acquired Galway-based Vivasure Medical in a transaction valued at up to €185 million, consisting of an upfront €100 million payment plus up to €85 million in contingent milestone payments. The acquisition adds Vivasure's PerQseal Elite fully bioabsorbable vascular closure system to Haemonetics' large-bore closure portfolio; Vivasure has CE Mark approvals and has submitted a PMA to the U.S. FDA.

Groupe HLD Acquires Photonis (now Exosens) from Ardian

November 18, 2025

Aerospace & Defense

Groupe HLD (HLD Europe) acquired Photonis Group (rebranded Exosens) from Ardian in 2021 in a reported €370 million buyout. Under HLD ownership Exosens expanded through nearly ten add-on acquisitions, grew to roughly 1,600–1,900 employees with ~€394m turnover, and completed an IPO on Euronext Paris in June 2024.

Haemonetics to Acquire Attune Medical

March 5, 2024

Healthcare Services

Haemonetics Corporation has entered into a definitive agreement to acquire privately held Attune Medical, the manufacturer of the ensoETM proactive esophageal cooling device used during RF cardiac ablation procedures. The deal calls for an upfront cash payment of $160 million at closing, plus additional contingent consideration tied to sales growth and other milestones, and is expected to close in Haemonetics’ fiscal first quarter of 2025.

Haemonetics Acquires Cardiva Medical

January 20, 2021

Medical Devices

Haemonetics Corporation agreed to acquire Cardiva Medical, Inc., a privately-held maker of vascular closure systems based in Santa Clara, California, for $475 million upfront and up to $35 million in contingent consideration. The acquisition expands Haemonetics' hospital portfolio and its presence in the interventional cardiology and electrophysiology markets and is expected to be accretive to revenue growth.